EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

L1CAM Promotes the Infiltrative Properties of Patient‐Derived Glioblastoma Cells

Asako Katsuma, Daisuke Kanematsu, Yukako Handa, Tomoko Shofuda, Atsuyo Yamamoto, Kayo Nishitani, Zhize Xiao, Daisuke Kawauchi, Kentarou Baba, Naoyuki Inagaki, Yonehiro Kanemura iD

Cancer Science · 2026

DOI: 10.1111/cas.70359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Asako Katsuma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Os…. Hauptthemen laut MEDLINE: Neural Cell Adhesion Molecule L1, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Osaka Foundation for Incurable Diseases, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L1CAM is a member of the immunoglobulin superfamily involved in cell adhesion, migration, and neural development. While several studies have shown an association between L1CAM and glioblastoma (GBM) cell motility, its mechanobiological function in patient‐derived primary cultured GBM cells remains insufficiently understood. This study focuses on L1CAM‐dependent motility mechanisms in patient‐derived GBM cells at the single‐cell level. Patient‐derived GBM cells were established from GBM tissues using the neurosphere method. L1CAM expression was evaluated by qPCR, western blotting, flow cytometry, and immunocytochemistry. Cell motility was assessed by single‐cell tracking. Functional assays included forced expression and antibody‐mediated inhibition of L1CAM. Adhesion‐clutch behavior and retrograde F‐actin flow were analyzed. For in vivo assessment, doxycycline‐inducible L1CAM‐overexpressing GBM cells were transplanted into mouse brains. L1CAM‐high GBM cells showed increased motility on laminin compared to L1CAM‐low cells. Anti‐L1CAM antibody suppressed migration of L1CAM‐high GBM cells, whereas ectopic expression enhanced migration in L1CAM‐low GBM cells. L1CAM‐positive GBM cells preferentially migrated on laminin rather than fibronectin, while L1CAM‐low cells showed no such difference, indicating L1CAM‐dependent haptotaxis. Forced L1CAM expression reduced retrograde actin flow velocity and promoted adhesion‐clutch formation. In vivo, GBM cells with L1CAM overexpression displayed greater infiltrative capacity 12 weeks posttransplantation. L1CAM expression on GBM cells' surface regulates cell motility through adhesion‐clutch mechanisms and substrate sensing. These mechanobiological features suggest that targeting L1CAM may serve as a promising strategy to suppress GBM cells infiltration and improve GBM treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Cell Adhesion Molecule L1GlioblastomaBrain NeoplasmsHumansAnimalsCell MovementMiceCell AdhesionCell Line, TumorActinsLamininFemale

Stichwörter der Autor:innen

L1CAMadhesion‐clutchcell motilityglioblastomahaptotaxis

Substanzen

Neural Cell Adhesion Molecule L1L1CAM protein, humanActinsLaminin

Autor:innen und Institutionen

  • Division of Regenerative Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.
  • Laboratory of Systems Neurobiology and Medicine, Division of Biological Science, Nara Institute of Science and Technology, Ikoma, Nara, Japan.
  • Division of Molecular Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.
  • Division of Stem Cell Research, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.
  • Department of Neuro-Oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
  • Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Tokyo, Japan.

ORCID-Profile: Yonehiro Kanemura

Förderung

  • The Osaka Foundation for Incurable Diseases
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Katsuma, A., Kanematsu, D., Handa, Y., Shofuda, T., Yamamoto, A., Nishitani, K., Xiao, Z., Kawauchi, D., Baba, K., Inagaki, N., & Kanemura, Y. (2026). L1CAM Promotes the Infiltrative Properties of Patient‐Derived Glioblastoma Cells. Cancer Science. https://doi.org/10.1111/cas.70359

Vancouver

Katsuma A, Kanematsu D, Handa Y, Shofuda T, Yamamoto A, Nishitani K, et al. L1CAM Promotes the Infiltrative Properties of Patient‐Derived Glioblastoma Cells. Cancer Science. 2026. doi:10.1111/cas.70359

BibTeX
@article{Katsuma2026,
  author = {Katsuma, Asako and Kanematsu, Daisuke and Handa, Yukako and Shofuda, Tomoko and Yamamoto, Atsuyo and Nishitani, Kayo and Xiao, Zhize and Kawauchi, Daisuke and Baba, Kentarou and Inagaki, Naoyuki and Kanemura, Yonehiro},
  title = {L1CAM Promotes the Infiltrative Properties of Patient‐Derived Glioblastoma Cells},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70359}
}
Kostenlos starten →